CEO pay
What US-listed companies paid their chief executive, highest first, from the pay-versus-performance table each company files with the SEC. “Total pay” is the figure in the summary compensation table; “actually paid” is the SEC's measure that marks share awards to their current value, so it can be far higher or even negative.
Median CEO pay, fiscal 2025
$4.8 M
603 companies
Median of the other top executives
$2.0 M
average per company
CEOs paid $50 M or more
4
Years on file
2020–2026
Sector:AllBasic MaterialsCommunication ServicesConsumer CyclicalConsumer DefensiveEnergyFinancial ServicesHealthcareIndustrialsReal EstateTechnologyUtilities
| # | Company | CEO total pay | Actually paid | Other executives, average | CEO vs others | $100 invested | Filing |
|---|---|---|---|---|---|---|---|
| 1 | 🇺🇸 Veeva Systems Inc.Mr. Gassner | $172.4 M | $284.2 M | $2.7 M | 63× | $84 | Proxy |
| 2 | 🇨🇭 Roivant Sciences Ltd.Matthew Gline | $163.3 M | $120.3 M | $55.0 M | 3× | $204 | Proxy |
| 3 | 🇺🇸 Thermo Fisher Scientific Inc.Mr. Casper | $79.9 M | $116.1 M | $7.6 M | 10.5× | $126 | Proxy |
| 4 | 🇺🇸 UnitedHealth Group IncorporatedChief executive (2 people held the post) | $60.9 M | $56.5 M | $19.0 M | 3.2× | $102 | Proxy |
| 5 | 🇺🇸 Tenet Healthcare CorporationDr. Sutaria | $43.1 M | $149.4 M | $7.8 M | 5.6× | $498 | Proxy |
| 6 | 🇺🇸 Tempus AI, Inc.Eric Lefkofsky | $41.5 M | $67.9 M | $7.3 M | 5.7× | $147 | Proxy |
| 7 | 🇺🇸 Waystar Holding Corp.Mr. Hawkins | $37.1 M | $18.7 M | $11.0 M | 3.4× | $158 | Proxy |
| 8 | 🇺🇸 Eli Lilly and CompanyMr. Ricks | $36.7 M | $75.2 M | $10.9 M | 3.4× | $671 | Proxy |
| 9 | 🇺🇸 Ocular Therapeutix, Inc.Dr. Dugel | $35.9 M | $57.5 M | $3.5 M | 10.2× | $59 | Proxy |
| 10 | 🇺🇸 Scholar Rock Holding CorporationChief executive (2 people held the post) | $33.3 M | $44.3 M | $13.6 M | 2.5× | $487 | Proxy |
| 11 | 🇺🇸 Johnson & JohnsonJ. Duato | $32.8 M | $68.3 M | $12.5 M | 2.6× | $152 | Proxy |
| 12 | 🇺🇸 AbbVie Inc.Mr. Michael | $32.5 M | $57.4 M | $12.1 M | 2.7× | $259 | Proxy |
| 13 | 🇺🇸 Incyte CorporationChief executive (2 people held the post) | $32.1 M | $54.7 M | $6.3 M | 5.1× | — | Proxy |
| 14 | 🇺🇸 Inhibikase Therapeutics, Inc.Mark Iwicki, Milton Werner (2 people held the post) | $30.6 M | $29.7 M | $6.5 M | 4.7× | $161 | Proxy |
| 15 | 🇺🇸 XBiotech Inc.Dr. Sushma Shivaswamy | $30.1 M | $27.1 M | $385 K | 78.3× | — | Proxy |
| 16 | 🇺🇸 Baxter International Inc.Mr. Hider, Mr. Almeida, Mr. Shafer (3 people held the post) | $29.8 M | $14.7 M | $5.2 M | 5.7× | $27 | Proxy |
| 17 | 🇺🇸 Gilead Sciences, Inc.Mr. O’Day | $28.4 M | $63.3 M | $9.2 M | 3.1× | $255 | Proxy |
| 18 | 🇺🇸 IQVIA Holdings Inc.Ari Bousbib | $28.1 M | $36.1 M | $8.9 M | 3.2× | $126 | Proxy |
| 19 | 🇺🇸 Cogent Biosciences, Inc.Chief executive | $27.8 M | $116.8 M | $8.9 M | 3.1× | $414 | Proxy |
| 20 | 🇺🇸 Pfizer Inc.Bourla | $27.6 M | $33.7 M | $9.6 M | 2.9× | $86 | Proxy |
| 21 | 🇺🇸 Stoke Therapeutics, Inc.Edward M. Kaye, M.D (2 people held the post) | $27.0 M | $31.1 M | $2.1 M | 13.2× | $344 | Proxy |
| 22 | 🇺🇸 HCA Healthcare, Inc.Hazen | $26.5 M | $78.2 M | $8.2 M | 3.2× | $296 | Proxy |
| 23 | 🇺🇸 Benitec Biopharma Inc.Dr. Jerel A | $25.9 M | $26.7 M | $6.2 M | 4.2× | $289 | Proxy |
| 24 | 🇺🇸 TG Therapeutics, Inc.Mr. Weiss | $25.6 M | $28.3 M | $3.8 M | 6.8× | $57 | Proxy |
| 25 | 🇺🇸 Amgen Inc.Mr. Bradway | $24.7 M | $49.4 M | $8.5 M | 2.9× | $167 | Proxy |
| 26 | 🇺🇸 Abbott LaboratoriesRobert B. Ford | $24.2 M | $26.8 M | $7.5 M | 3.2× | — | Proxy |
| 27 | 🇺🇸 Danaher CorporationRainer Blair | $23.8 M | $17.3 M | $9.2 M | 2.6× | $119 | Proxy |
| 28 | 🇺🇸 Biogen Inc.Mr. Viehbacher | $23.6 M | $27.7 M | $5.9 M | 4× | $72 | Proxy |
| 29 | 🇺🇸 Harrow HealthMark Baum (2 people held the post) | $23.6 M | — | $3.6 M | 6.6× | $714 | Proxy |
| 30 | 🇺🇸 Boston Scientific CorporationMichael F. Mahoney | $23.5 M | $33.0 M | $5.8 M | 4× | $265 | Proxy |
| 31 | 🇺🇸 GoodRxBarnes | $23.4 M | $14.2 M | $2.4 M | 9.7× | $5 | Proxy |
| 32 | 🇺🇸 PTC Therapeutics, Inc.Matthew Klein | $23.3 M | $41.2 M | $3.4 M | 6.9× | $125 | Proxy |
| 33 | 🇺🇸 Halozyme Therapeutics, Inc.Helen I Torley | $23.2 M | $39.7 M | $3.6 M | 6.4× | $158 | Proxy |
| 34 | 🇺🇸 The Cigna GroupDavid M. Cordani | $22.9 M | $14.6 M | $6.9 M | 3.3× | $145 | Proxy |
| 35 | 🇺🇸 Elevance Health, Inc.Gail Boudreaux | $22.6 M | $18.8 M | $7.2 M | 3.1× | $117 | Proxy |
| 36 | 🇺🇸 BioMarin Pharmaceutical Inc.Alexander Hardy (2 people held the post) | $21.9 M | $12.2 M | $6.4 M | 3.5× | $68 | Proxy |
| 37 | 🇺🇸 Bristol-Myers Squibb CompanyDr. Chris Boerner | $21.9 M | $16.9 M | $9.2 M | 2.4× | $105 | Proxy |
| 38 | 🇺🇸 Stryker CorporationMr. Lobo | $21.4 M | $24.8 M | $4.6 M | 4.6× | $151 | Proxy |
| 39 | 🇺🇸 Viking Therapeutics, Inc.Brian Lian | $21.3 M | $7.5 M | $5.1 M | 4.1× | $625 | Proxy |
| 40 | 🇺🇸 Medtronic plcGeoff Martha (2 people held the post) | $21.2 M | $26.1 M | $5.6 M | 3.8× | $98 | Proxy |
| 41 | 🇺🇸 CVS Health CorporationJ. David Joyner | $21.2 M | $50.5 M | $10.4 M | 2× | $137 | Proxy |
| 42 | 🇺🇸 Vertex Pharmaceuticals IncorporatedReshma Kewalramani | $21.1 M | $38.2 M | $7.7 M | 2.7× | $192 | Proxy |
| 43 | 🇺🇸 Intuitive Surgical, Inc.Chief executive (2 people held the post) | $21.0 M | $26.4 M | $6.4 M | 3.3× | $287 | Proxy |
| 44 | 🇺🇸 Merck & Co., Inc.Mr. Davis | $20.8 M | $15.8 M | $6.9 M | 3× | $158 | Proxy |
| 45 | 🇺🇸 McKesson CorporationChief executive | $20.2 M | $39.2 M | $5.0 M | 4.1× | $353 | Proxy |
| 46 | 🇺🇸 Solventum CorporationBryan C. Hanson | $20.1 M | $40.0 M | $5.1 M | 4× | $115 | Proxy |
| 47 | 🇺🇸 Moderna, Inc.Mr. Bancel | $19.9 M | $15.8 M | $9.8 M | 2× | — | Proxy |
| 48 | 🇺🇸 Centene CorporationLondon (2 people held the post) | $19.5 M | $4.6 M | $7.7 M | 2.5× | $69 | Proxy |
| 49 | 🇺🇸 Madrigal Pharmaceuticals, Inc.Bill Sibold | $19.2 M | $84.1 M | $6.6 M | 2.9× | $524 | Proxy |
| 50 | 🇺🇸 Align Technology, Inc.Joseph Hogan | $19.2 M | $3.9 M | $4.3 M | 4.4× | $29 | Proxy |
Source: SEC proxy statements (Form DEF 14A), pay-versus-performance table. “$100 invested” is the company's own total-shareholder-return figure over the years of its table. When the post changed hands in a year, the highest-paid chief executive is shown